Aoki et al., 1984 - Google Patents
Modification of the hyperosmotic infiltration method of vaccination against vibriosis in cultured ayu, Plecoglossus altivelis Temminck and SchlegelAoki et al., 1984
- Document ID
- 7558517879912877704
- Author
- Aoki T
- Kitao T
- Fukudome M
- Takahashi S
- Egusa S
- Publication year
- Publication venue
- Journal of Fish Diseases
External Links
Snippet
A vaccine solution of a formalin‐killed culture of Vibrio anguillarum cells was observed to be toxic to young ayu when administered by the hyperosmotic infiltration method. The toxin was present in the culture broth. After the toxin was removed from the broth by centrifugation, the …
- 241000861915 Plecoglossus 0 title abstract description 31
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fryer et al. | Vaccination for control of infectious diseases in Pacific salmon | |
| Gould et al. | Spray vaccination: a method for the immunization of fish | |
| DK175512B1 (en) | Avirulent microbes and applications therefore | |
| Esteve-Gassent et al. | Efficacy of a bivalent vaccine against eel diseases caused by Vibrio vulnificus after its administration by four different routes | |
| Li et al. | Protective effects of chicken egg yolk antibody (IgY) against experimental Vibrio splendidus infection in the sea cucumber (Apostichopus japonicus) | |
| Agius et al. | Immunization of rainbow trout, Salmo gairdneri Richardson, against vibriosis: comparison of an extract antigen with whole cell bacterins by oral and intraperitoneal routes | |
| Thune et al. | A comparison of immersion, immersion/oral combination and injection methods for the vaccination of channel catfish Ictalurus punctatus against Edwardsiella ictaluri | |
| Antipa et al. | Vibrio anguillarum vaccination of sockeye salmon Oncorhynchus nerka (Walbaum) by direct and hyperosmotic immersion. | |
| Paterson et al. | The immune response of Atlantic salmon, Salmo salar L., to the causative agent of bacterial kidney disease, Renibacterium salmoninarum | |
| Tapa et al. | Controlled field trial on the effectiveness of one and two doses of acetone-inactivated and dried typhoid vaccine | |
| Grayson et al. | Effects of immunopotentiating agents on the immune response of rainbow trout, Salmo gair dneri Richardson, to ERM vaccine | |
| Santos et al. | Efficacy of furunculosis vaccines in turbot, Scophthalmus maximus (L.): evaluation of immersion, oral and injection delivery | |
| Aoki et al. | Modification of the hyperosmotic infiltration method of vaccination against vibriosis in cultured ayu, Plecoglossus altivelis Temminck and Schlegel | |
| Birkbeck et al. | Infectivity of a Scottish isolate of Piscirickettsia salmonis for Atlantic salmon Salmo salar and immune response of salmon to this agent | |
| Ispir et al. | Efficacy of lipopolysaccharide antigen of Yersinia ruckeri in rainbow trout by intraperitoneal and bath immersion administration | |
| Thune et al. | Effect of delivery method and antigen preparation on the production of antibodies against Aeromonas hydrophila in channel catfish | |
| Amend et al. | Evidence for lack of antigenic competition among various combinations of Vibrio anguillarum, Yersinia ruckeri, Aeromonas salmonicida and Renibacterium salmoninarum bacterins when administered to salmonid fishes | |
| McCarthy et al. | Immunization of rainbow trout, Salmo gairdneri Richardson, against bacterial kidney disease: preliminary efficacy evaluation | |
| Edelman | Prevention and treatment of infectious diarrhea: speculations on the next 10 years | |
| AOKI et al. | Protective immunity in ayu, Plecoglossus altivelis, vaccinated by immersion with Vibrio anguillarum | |
| Bullock | Furunculosis and other diseases caused by Aeromonas salmonicida | |
| Gudmundsdóttir et al. | Evaluation of cross protection by vaccines against atypical and typical furunculosis in Atlantic salmon, Salmo salar L. | |
| Soltani et al. | Protection of Persian sturgeon (Acipenser persicus) fingerling against Aeromonas hydrophila septicemia using three different antigens | |
| Quentel et al. | Vaccination of juvenile turbot, Scophthalmus maximus L., against vibriosis | |
| Bullock | Enteric redmouth disease of salmonids |